Spero Therapeutics, Inc. Quarterly Current Ratio in % from Q2 2018 to Q3 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Spero Therapeutics, Inc. quarterly Current Ratio history and growth rate from Q2 2018 to Q3 2024.
  • Spero Therapeutics, Inc. Current Ratio for the quarter ending September 30, 2024 was 302 %, a 34.9% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 302 -162 -34.9% Sep 30, 2024
Q2 2024 330 -126 -27.5% Jun 30, 2024
Q1 2024 379 -46.9 -11% Mar 31, 2024
Q4 2023 411 +122 +42.1% Dec 31, 2023
Q3 2023 464 +130 +38.9% Sep 30, 2023
Q2 2023 456 +58.6 +14.7% Jun 30, 2023
Q1 2023 426 -21.9 -4.9% Mar 31, 2023
Q4 2022 289 -500 -63.4% Dec 31, 2022
Q3 2022 334 -481 -59% Sep 30, 2022
Q2 2022 397 -431 -52% Jun 30, 2022
Q1 2022 448 -275 -38% Mar 31, 2022
Q4 2021 790 +159 +25.1% Dec 31, 2021
Q3 2021 815 +325 +66.3% Sep 30, 2021
Q2 2021 828 +370 +80.7% Jun 30, 2021
Q1 2021 723 +159 +28.2% Mar 31, 2021
Q4 2020 631 -125 -16.5% Dec 31, 2020
Q3 2020 490 -591 -54.7% Sep 30, 2020
Q2 2020 458 -840 -64.7% Jun 30, 2020
Q1 2020 564 -676 -54.5% Mar 31, 2020
Q4 2019 756 -409 -35.1% Dec 31, 2019
Q3 2019 1.08K -137 -11.3% Sep 30, 2019
Q2 2019 1.3K +318 +32.4% Jun 30, 2019
Q1 2019 1.24K Mar 31, 2019
Q4 2018 1.17K Dec 31, 2018
Q3 2018 1.22K Sep 30, 2018
Q2 2018 980 Jun 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.